Trump’s Big Choice on Drug Prices

Dean Obeidallah: Inflation Reduction Act allows Medicare to negotiate drug prices with drug companies.

He says in year two , 15 more drugs are up for negotiation, with 20 per year starting in year four .

Negotiating prices for GLP-1s in particular will be critical given their popularity; as Sen. Bernie Sanders (I-VT) pointed out, Americans pay 15 times as much for Ozempic as Europeans as Europeans .

The price reduction could be worth tens of billions of dollars alone.

Many legal challenges to the law are ongoing; will Kennedy and the Justice Department continue to defend it in court? A recent revelation in the Senate confirmation process of Pam Bondi recently worked directly for drug giant Pfizer as a legal counsel, according to her financial disclosure form.

Trump only has to follow the law his predecessor teed up for him.